Atlas/Grants/Record
Atlas · Grant RecordFederal grant

L'Étang Ruisseau Bar Ltée

National Research Council Canada — Industrial Research Assistance Program – Contributions to Firms — $865,100

auto_awesome
Want to know who else bid on this?
Proposal Forge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Open the Bid Intelligence reportarrow_forward

Amount

$865.1K

Province

NB

Type

Contribution

Agreement Number

172-2025-2026-Q2-1031207

Purpose

The primary innovation, an MSX disease-resistant strain, will add tremendous value to ERB’s hatchery seed and will generate desirable impacts in the short term for ERB itself but also for the entire Maritimes industry, where MSX is currently located. ERB is already the primary supplier of hatchery seed in Atlantic Canada, and all companies sourcing seed from ERB will find value in disease-resistant strains as a risk-mitigation strategy to prevent economic loss. In the longer term, the incorporation of disease resistance will be a required component of any hatchery-produced seed to enable sustainable farming operations. Overall, the value proposition is quite simply assuring the continued survival of our entire industry.

L'Étang Ruisseau Bar Ltée × National Research Council Canada

6 grants totalling $3.0M

Industrial Research Assistance Program – Contributions to Firms

1,000 grants totalling $112.4M

Related Grants

RecipientAmountProgram
Entos Pharmaceuticals Inc.$10.0MIndustrial Research Assistance Program –...
Entos Pharmaceuticals Inc.$10.0MIndustrial Research Assistance Program –...
Laurent Pharmaceuticals Inc.$10.0MIndustrial Research Assistance Program –...
Laurent Pharmaceuticals Inc.$10.0MIndustrial Research Assistance Program –...
Providence Therapeutics Holdings Inc.$10.0MIndustrial Research Assistance Program –...